Brown Capital Management’s Myriad Genetics MYGN Stock Holding History

Brown Capital Management’s Portfolio MYGN Stock Details MYGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-127,251	Closed	-$4.77M	–	132
2015 Q3	$4.77M	Sell	127,251 -4,079	-3%	-$145K	0.08%	80
2015 Q2	$4.46M	Buy	131,330 +24,147	+23%	+$821K	0.07%	90
2015 Q1	$3.79M	Sell	107,183 -10,671	-9%	-$382K	0.06%	92
2014 Q4	$4.01M	Sell	117,854 -11,233	-9%	-$399K	0.07%	93
2014 Q3	$4.98M	Sell	129,087 -130,715	-50%	-$4.88M	0.09%	91
2014 Q2	$10.1M	Hold	259,802	–	–	0.17%	62
2014 Q1	$8.88M	Buy	259,802 +110,491	+74%	+$3.42M	0.15%	69
2013 Q4	$3.13M	Sell	149,311 -4,696	-3%	-$119K	0.05%	93
2013 Q3	$3.62M	Hold	154,007	–	–	0.06%	89
2013 Q2	$4.14M	Buy	+154,007	New	+$4.46M	0.09%	83

Other funds holding MYGN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Brown Capital Management's MYGN Position: Q4 2015 in Review

Brown Capital Management sold out of Myriad Genetics (MYGN) in Q4 2015, closing a stake of 127,251 shares — an estimated $4.77M sold.

Brown Capital Management first reported a position in MYGN in Q2 2013 and held it in 10 quarters. The position peaked at $10.1M in Q2 2014. 232 funds tracked by Wall St. Rank hold MYGN as of Q4 2015.

Brown Capital Management reported no remaining Myriad Genetics position as of Q4 2015 after selling out during the quarter.
Brown Capital Management sold 127,251 Myriad Genetics shares in Q4 2015, an estimated $4.77M.
Brown Capital Management first reported a position in Myriad Genetics in Q2 2013 and held it in 10 quarters.
Brown Capital Management's Myriad Genetics position peaked at $10.1M in Q2 2014.
232 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2015.

Based on Brown Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.